Kairos Biotech

Denbigh, United Kingdom

Kairos Biotech is an early stage company focusing on proprietary small molecule discovery applied to diagnostics and immunotherapy.

$1.1M raised

Feb 2023

Seed

Biotechnology Therapeutics

Top Investors

EchiumBio Holding BV

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kairos Biotech

How much funding has Kairos Biotech raised?

Kairos Biotech has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in February 2023.

Who are Kairos Biotech's investors?

Kairos Biotech's investors include EchiumBio Holding BV.

Where is Kairos Biotech headquartered?

Kairos Biotech is headquartered in Denbigh, United Kingdom.

What does Kairos Biotech do?

Kairos Biotech is an early stage company focusing on proprietary small molecule discovery applied to diagnostics and immunotherapy.

What stage is Kairos Biotech at?

Kairos Biotech is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2023.

MLA

"Kairos Biotech — Funding & Investors." VCBacked, February 1, 2023, https://www.vcbacked.co/company/kairos-biotech. Accessed July 3, 2026.

APA

VCBacked. (2023). Kairos Biotech — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/kairos-biotech

Wikipedia (cite web)

{{cite web |title=Kairos Biotech — Funding & Investors |url=https://www.vcbacked.co/company/kairos-biotech |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K